Biotechnology: Are you ready to meet the challenge?

Australian Journal of Hospital Pharmacy

Volumn 26, Issue 1, 1996, Pages 74-78

  DiPiro, Joseph T ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b Department of Surgery ^*

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038640376     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Anon. Biotechnology medicines in development; 1995 survey. Pharmaceutical Research and Manufacturers of America, 1995.
2. Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarcto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
3. ISIS Steering Committee. Intravenous streptokinase given with 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet 1987; 1: 502.
4. DiPiro JT, Hamilton RG, Wei JP. Novel antibody drug products. Am J Surg 1992; 164: 77-84.
5. Dillman RO. Monoclonal antibodies for treating cancer. Ann Intern Med 1989; 19: 592-603.
6. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991; 325: 164-70.